Deborah Arrindell is Executive Director/Therapeutic Area Head of Safety Oncology at Amgen.
She has been in the pharmaceutical industry since 2000 when she joined Roche Laboratories as Medical Director of Versed. Since that time Deborah has held various positions at Wyeth/Pfizer and Johnson and Johnson.
Deborah Arrindell attended Cornell University where she received a BS in biology. She then attended Yale University School of Medicine where she received her MD-MPH degree. Following two years of training in pediatrics, Deborah completed an anesthesiology and critical care training program at Johns Hopkins Hospital in Baltimore, Maryland. After spending a brief time in private practice anesthesia, Deborah returned to join the faculty at the Johns Hopkins Bayview Hospital as an Assistant Professor in Anesthesiology and Critical Care. During this time Deborah also obtained her law degree from the University Of Maryland School of Law. Deborah is admitted to the bar in New York, Maryland, and New Jersey.
Striving for excellence. Always being excellent in everything that you do. And you're right, the next opportunity will find you. That's the other thing, the also take home message. If you look at a lot of successful people, a lot of them don't apply for any of these positions, right? Somebody is...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
